Loading company…
Riskpilot
← Back to search
Sign in
Get full access
SwePharm AB
AB
Active
Org 5565760930
Sandby 1641
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 1999
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 51K
-86% vs 2023
EBITDA margin
-356.9%
+41% vs 2023
Equity ratio
46.8%
Financial strength
Net profit 2024
SEK 32K
-1% vs 2023
EBITDA — year on year
SEK millions
3M
2M
1M
-0M
-1M
1M
2020
2M
+100%
2021
-1M
-150%
2022
0M
+100%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 51K
-86%
EBITDA
SEK -182K
+41%
Net profit
SEK 32K
-1%
Total assets
SEK 1M
-28%
Equity
SEK 471K
-20%
Employees
0
—
Company information
Legal name
SwePharm AB
Org number
5565760930
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11 oktober 1999
Share capital
SEK 105 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget utvecklar, producerar, analyserar och säljer hälsorelaterade produkter från växter samt idkar därmed förenlig verksamhet.
Contact
Address
Sandby 1641
Phone
+464658393
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Lund
All Sweden companies
Revenue
SEK millions
0M
2M
4M
6M
8M
4M
2020
7M
2021
3M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
1M
1M
2M
2M
1M
2020
2M
2021
-1M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
3 532
7 010
2 588
361
51
Staff expenses
—
—
−213
−6
—
EBITDA
960
2 367
−704
−307
−182
Depreciation & amort.
−256
−269
−231
−147
−109
EBIT
704
2 098
−935
−454
−291
Net financials
510
−39
−40
27
−6
Profit before tax
739
1 678
398
32
32
Tax
−39
−348
−79
−0
−0
Net profit
700
1 330
319
32
32
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
5 289
7 927
5 053
1 389
1 006
Equity
1 008
2 338
2 657
589
471
Long-term debt
1 531
1 722
0
—
0
Short-term debt
576
1 311
1 213
76
140
Total debt
2 107
3 033
1 213
76
140
Financial ratios
5-year trend
EBITDA margin
-356.9%
This company
15.8%
Market median
-2359% vs market
2020
2024
Equity ratio
46.8%
This company
38.2%
Market median
+23% vs market
2020
2024
Return on equity
6.8%
This company
18.4%
Market median
-63% vs market
2020
2024
Net profit margin
62.7%
This company
8.1%
Market median
+674% vs market
2020
2024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
2020
2024
Debt / equity
1.14×
This company
0.62×
Market median
-84% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
GE
Gösta Edvard Lilius
Chief Executive Officer
Chief Executive Officer
2022
MM
Malin Maria Olbe
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2022
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of SwePharm AB also hold positions in
0
other companies.
Person
Role here
Other companies
Gösta Edvard Lilius
Chief Executive Officer
0 companies
Malin Maria Olbe
Deputy Chief Executive Officer
0 companies